SCANDINAVIAN TRIAL OF AN ORAL-CONTRACEPTIVE CONTAINING 0.150 MG DESOGESTREL AND 0.030 MG ETHINYLESTRADIOL

被引：0

作者：

BORGLIN, NE

CHRISTENSEN, OJE

CULLBERG, G

ENGER, L

FJAERESTAD, I

KLOTTRUP, P

ODLIND, V

SANDAGER, T

SECHER, K

ASSENDORP, R

机构：

[1] GYNECOL PRACTICE,MALMO,SWEDEN

[2] OSTFOLD,DEPT GYNECOL SENTRALSYKEHUSET,FREDERIKSTAD,NORWAY

[3] LASARETTET,DEPT GYNECOL,KARLSKOGA,SWEDEN

[4] MED PRACTICE,HERNING,DENMARK

[5] MED PRACT,FARUM,DENMARK

[6] OSTRA SJUKHUSET,DEPT INTERNAL MED,S-41685 GOTHENBURG,SWEDEN

[7] SENTRALSYKEHUSET,DEPT GYNECOL & OBSTET,KRISTIANSTAD,NORWAY

[8] CARLANDERSKA SJUKHEMMET,GOTHENBURG,SWEDEN

[9] UNIV UPPSALA HOSP,DEPT OBSTET & GYNECOL,S-75014 UPPSALA,SWEDEN

[10] ORGANON SCI DEV GRP,OSS,NETHERLANDS

来源：

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA | 1982年

关键词：

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：39 / 42

页数：4

共 50 条

[1] COMPARATIVE EFFECTS OF THE ORAL-CONTRACEPTIVE COMBINATIONS 0.150 MG DESOGESTREL + 0.030 MG ETHINYLESTRADIOL AND 0.150 MG LEVONORGESTREL + 0.030 MG ETHINYLESTRADIOL ON LIPID AND LIPOPROTEIN METABOLISM IN HEALTHY FEMALE VOLUNTEERS
SAMSIOE, G
[J]. CONTRACEPTION, 1982, 25 (05) : 487 - 504
[2] BELGIAN TRIAL OF AN ORAL-CONTRACEPTIVE CONTAINING 0.150-MG DESOGESTREL AND 0.020-MG ETHINYLESTRADIOL
VANKETS, HE
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 13 - 17
[3] GERMAN TRIAL OF AN ORAL-CONTRACEPTIVE CONTAINING 0.150-MG DESOGESTREL PLUS 0.020-MG ETHINYLESTRADIOL
NEVINNYSTICKEL, J
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 19 - 21
[4] EVALUATION OF AN ORAL-CONTRACEPTIVE CONTAINING 0.150-MG DESOGESTREL AND 0.020-MG ETHINYLESTRADIOL IN WOMEN AGED 30 YEARS OR OLDER
STEFFENSEN, K
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 23 - 27
[5] CLINICAL-STUDIES WITH A NEW, LOW-DOSE ORAL-CONTRACEPTIVE COMBINATION, CONTAINING 0.150 MG DESOGESTREL AND 0.020 MG ETHINYLESTRADIOL - FOREWORD
ALAPIESSA, U
LOK, D
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 5 - 5
[6] EVALUATION OF AN ORAL-CONTRACEPTIVE CONTAINING 0.050 MG ETHINYLESTRADIOL AND 0.125 MG DESOGESTREL IN A NORMOPHASIC REGIMEN
WEIJERS, MJ
[J]. FORTSCHRITTE DER MEDIZIN, 1982, 100 (16) : 764 - 767
[7] A CLINICAL COMPARISON IN FINLAND OF 2 ORAL-CONTRACEPTIVES CONTAINING 0.150-MG DESOGESTREL IN COMBINATION WITH 0.020-MG OR 0.030-MG ETHINYLESTRADIOL
TUIMALA, R
SARANEN, M
ALAPIESSA, U
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 7 - 12
[8] ROUTINE LIVER-FUNCTION TESTING DURING LONG-TERM ADMINISTRATION OF THE ORAL-CONTRACEPTIVE PREPARATION 0.150 MG DESOGESTREL PLUS 0.030 MG ETHINYLESTRADIOL TO HEALTHY FEMALE VOLUNTEERS IN SCANDINAVIA
ODLIND, V
BORGLIN, NE
CHRISTENSEN, OJE
CULLBERG, G
ENGER, L
FJAERESTAD, I
KLOTTRUP, P
SANDAGER, T
SECHER, K
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1982, : 43 - 46
[9] EFFECTS OF THE ORAL-CONTRACEPTIVE COMBINATION 0.150-MG DESOGESTREL +0.020-MG ETHINYLESTRADIOL ON SERUM-LIPIDS INCLUDING THE HDL SUBFRACTIONS
KLOOSTERBOER, HJ
VANWAYJEN, RGA
VANDENENDE, A
[J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, : 33 - 36
[10] EFFECTS OF AN ORAL-CONTRACEPTIVE COMBINATION CONTAINING 0.150 MG DESOGESTREL PLUS 0.020 MG ETHINYL ESTRADIOL ON HEALTHY PREMENOPAUSAL WOMEN
DEALOYSIO, D
MAULONI, M
RONCUZZI, A
ALTIERI, P
BOTTIGLIONI, F
TROSSARELLI, GF
FANIZZA, G
COVELLI, A
[J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1993, 253 (01) : 15 - 19

← 1 2 3 4 5 →